rss
J Am Med Inform Assoc 14:264-268 doi:10.1197/jamia.M2177
  • The Practice of Informatics

Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy Toxicities

Table 1

Questions and Considerations When Developing an Electronic PRO Questionnaire Platform

Catagory Questions Considerations
Questionnaire platform Paper vs. electronic? Cost, development time, data volume
If electronic, what hardware type (Web, PDA, IVR)? Cost, hardware availability, training, maintenance
Internal software development vs. third-party product? Cost, time, technical support, updates
Data storage in standard/exportable format? Yes, because cannot anticipate future needs
Questionnaire content Use existing instrument vs. original development? Objectives of research/data use
Verify adequate validation of instrument? Re-validation for major modifications
Appropriate to target population? Prior use in similar patients or disease
PHI privacy Institutional privacy review? Privacy board or IRB, HIPAA officer
Security (polarized) screens on monitors? Computer locations
Password protection? Encryption, user modification, secure recovery
Remote access to system vs. limited local access? Objectives of research
Disclaimer at login? Legal/liability issues
Data security Institutional security review? IRB, IS department
Secure system configuration and database? System validation, automated audit trail
Login timeout? Functionality, institutional requirements
Patient safety Automated warnings for concerning responses? Content of questionnaire items, liability, safety
Remote access to previously entered data? Objectives of system, privacy, security
  • PRO = patient reported outcomes; PDA = personal digital assistant; IVR = integrated voice response; PHI = protected health information; IRB = institutional review board; HIPAA = Health Insurance Portability and Accountability Act; CAT = computerized adaptive testing; IRT = item response theory; IS = Information Services; UAT = user acceptance testing.

This Article

Access policy for JAMIA

All content published in JAMIA is deposited with PubMed Central by the publisher with a 12 month embargo. Authors/funders may pay an Unlocked fee of $2,000 to make the article free on the JAMIA website and PMC immediately on publication.

All content older than 12 months is freely available on this website.

AMIA members can log in with their JAMIA user name (email address) and password or via the AMIA website.